Ann: NYR-BI03 Phase Ia Clinical Trial Update - Correction, page-31

  1. 1,238 Posts.
    lightbulb Created with Sketch. 157
    Any biotech in this position that has 8-10 million in cash trades 50-70 million market caps. The drug itself is transformative and this garbage market cap of 18 million market caps is a pathetic joke. This will become a 100 million dollar plus market cap.

    It’s here because they moved the first human dosing to Jan from Dec and the traders taking loses like donkeys like a month makes a difference. Comes down and comes straight back up in the period ahead. Being manipulated and the likes of many waiting for 2 weeks to buy in again with news flow coming in and run it back up. Investors no such things just wankers
    Last edited by Bendunstan: 20/12/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
22.5¢
Change
-0.025(10.0%)
Mkt cap ! $47.45M
Open High Low Value Volume
25.0¢ 25.0¢ 22.5¢ $209.3K 892.7K

Buyers (Bids)

No. Vol. Price($)
1 7150 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 416666 1
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.